|
NPH patients (Mean (SD))
|
SAE patients (Mean (SD))
|
Laboratory reference values ((SD))
| |
| Albumin ratio | 9.5 (7.4) | 11.3 (7.0) | <10 | |
| Transmitter function: |
| HVA (nmol/l) | 215 (145) | 247 (108) | 253 (109) | n=11433 |
| 5-HIAA (nmol/l) | 113 (75) | 148 (52)4-150
| 125 (54) | n=11433 |
| HMPG (nmol/l) | 37 (16) | 39 (8) | 47 (10) | n=11433 |
| NPY (pmol/l) | 101 (33) | 117 (15)4-160
| 120–17036
| |
| VIP (pmol/l) | 7.3 (3.7) | 8.9 (2.4)4-160
| <2037
| |
| GABA (nmol/l) | 67 (35) | 79 (25)4-150
| 50–13040
| |
| Demyelination: |
| Sulfatide (nmol/l) | 206 (99) | 766 (957)4-165
| <30033
| |
| Gliosis: |
| GD3 (nmol/l) | 38 (23) | 43 (11) | 50 (12) | n=10139
|
| GFAP (ng/l) | 1492 (950) | 1194 (765) | <75041
| |
| S100 (μg/l) | 2.7 (0.9) | 2.6 (0.8) | <5 | |
| Neuronal degeneration: |
| NFL (ng/l) | 2252 (4084) | 1111 (704) | <30042
| |
| TAU (ng/l) | 265 (255) | 139 (78) | <40038
| |
| NSE (μg/l) | 5.2 (3.3) | 4.4 (1.5) | <10.5 | |